| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From The Morton and Gloria Shulman Movement Disorder Centre (Drs. Grimes and Lang) and the Centre for Research in Neurodegenerative Disease (Dr. Bergeron), Toronto, Canada.
Address correspondence and reprint requests to Dr. Anthony E. Lang, The Toronto Hospital, 399 Bathurst St., MP 11, Toronto, Ontario, M5T 2S8 Canada.
OBJECTIVE: To evaluate the clinical presentations and dominant symptoms of patients with postmortem proven cortical–basal ganglionic degeneration (CBGD) from one neuropathology center.
BACKGROUND: CBGD is a rare but increasingly recognized condition with clinical and pathologic features that continue to evolve. Attempts have been made to develop clinical criteria to enhance the specificity of diagnosis, but it is not clear what proportion of patients harboring CBGD disease present in the "classical" fashion versus other presentations. Previous large-case series that emphasize a parietal/perceptual-motor presentation may be biased because the cases mainly originate from movement disorder centers.
METHODS: Thirteen cases of pathologically confirmed CBGD with sufficient clinical data were identified from a single neuropathology center between 1981 and 1996.
RESULTS: Before death, only 4 of the 13 patients had a clinical diagnosis of CBGD, 6 had a clinical diagnosis of Alzheimer’s disease (AD), 1 had AD and parkinsonism, and 2 had an atypical dementia of the frontotemporal type. Nine of 13 cases had early dementia.
CONCLUSIONS: Dementia was the most common presentation of CBGD in this study. Despite the best efforts to define criteria to enhance the specificity of a diagnosis of CBGD, it is becoming clear that the clinical syndrome that accompanies this disease is quite varied. Unfortunately, patients fulfilling classical diagnostic criteria may represent a minority of those with this pathologic diagnosis.
Key words: Cortical-basal ganglionic degeneration—Dementia—Frontotemporal dementia.
This article has been cited by other articles:
|
|
 |
|
  A. S. Chen-Plotkin, W. Yuan, C. Anderson, E. M. Wood, H. I. Hurtig, C. M. Clark, B. L. Miller, V. M.-Y. Lee, J. Q. Trojanowski, M. Grossman, et al. Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations Neurology, February 12, 2008; 70(7): 521 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Grossman, D. J. Libon, M. S. Forman, L. Massimo, E. Wood, P. Moore, C. Anderson, J. Farmer, A. Chatterjee, C. M. Clark, et al. Distinct Antemortem Profiles in Patients With Pathologically Defined Frontotemporal Dementia Arch Neurol, November 1, 2007; 64(11): 1601 - 1609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Murray, M. Neumann, M. S. Forman, J. Farmer, L. Massimo, A. Rice, B. L. Miller, J. K. Johnson, C. M. Clark, H. I. Hurtig, et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration Neurology, April 17, 2007; 68(16): 1274 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Libon, S. X. Xie, P. Moore, J. Farmer, S. Antani, G. McCawley, K. Cross, and M. Grossman Patterns of neuropsychological impairment in frontotemporal dementia Neurology, January 30, 2007; 68(5): 369 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Masellis, P. Momeni, W. Meschino, R. Heffner Jr, J. Elder, C. Sato, Y. Liang, P. S. George-Hyslop, J. Hardy, J. Bilbao, et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome Brain, November 1, 2006; 129(11): 3115 - 3123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. McMonagle, M. Blair, and A. Kertesz Corticobasal degeneration and progressive aphasia Neurology, October 24, 2006; 67(8): 1444 - 1451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Soliveri, S. Piacentini, and F. Girotti Limb apraxia in corticobasal degeneration and progressive supranuclear palsy Neurology, February 8, 2005; 64(3): 448 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Seritan, M. F. Mendez, D. H.S. Silverman, R. A. Hurley, and K. H. Taber Functional Imaging as a Window to Dementia: Corticobasal Degeneration J Neuropsychiatry Clin Neurosci, November 1, 2004; 16(4): 393 - 399. [Full Text] [PDF]
|
|
|
|
|
|
M. Grossman, C. McMillan, P. Moore, L. Ding, G. Glosser, M. Work, and J. Gee What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration Brain, March 1, 2004; 127(3): 628 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Knopman, B. F. Boeve, and R. C. Petersen Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia Mayo Clin. Proc., October 1, 2003; 78(10): 1290 - 1308. [Abstract] [PDF]
|
|
|
|
 |
|
 M D Greicius, M D Geschwind, and B L Miller Presenile dementia syndromes: an update on taxonomy and diagnosis J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 691 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Forman, V. Zhukareva, C. Bergeron, S. S.-M. Chin, M. Grossman, C. Clark, V. M.-Y. Lee, and J. Q. Trojanowski Signature Tau Neuropathology in Gray and White Matter of Corticobasal Degeneration Am. J. Pathol., June 1, 2002; 160(6): 2045 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kertesz, P. Martinez-Lage, W. Davidson, and D. G. Munoz The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia Neurology, November 14, 2000; 55(9): 1368 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P L LANTOS, J. XUEREB, and J. HODGES Diagnostic criteria for corticobasal degeneration J. Neurol. Neurosurg. Psychiatry, November 1, 2000; 69(5): 705a - 706. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
